|
SNX18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64579461170433E-12 |
| Normal-vs-Stage2 |
5.47769996028791E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.655800E-01 |
| Stage1-vs-Stage3 |
8.824200E-03 |
| Stage1-vs-Stage4 |
5.94489999999892E-05 |
| Stage2-vs-Stage3 |
2.241400E-01 |
| Stage2-vs-Stage4 |
4.207700E-02 |
| Stage3-vs-Stage4 |
1.238800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62592161956354E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
3.801700E-03 |
| Caucasian-vs-AfricanAmerican |
7.356700E-03 |
| Caucasian-vs-Asian |
6.745600E-01 |
| AfricanAmerican-vs-Asian |
1.413810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62558855265615E-12 |
| Normal-vs-Female |
3.33066907387547E-16 |
| Male-vs-Female |
5.159800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.29990043571138E-10 |
| Normal-vs-Age(41-60Yrs) |
1.4432899320127E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62547753035369E-12 |
| Normal-vs-Age(81-100Yrs) |
5.31152899441167E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.018200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.730000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.173000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.630600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.588400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.944000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.10960027224871E-10 |
| Normal-vs-Grade 2 |
1.72395431263794E-12 |
| Normal-vs-Grade 3 |
1.11022302462516E-16 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
3.696400E-01 |
| Grade 1-vs-Grade 3 |
6.953400E-01 |
| Grade 1-vs-Grade 4 |
9.002200E-02 |
| Grade 2-vs-Grade 3 |
1.047630E-02 |
| Grade 2-vs-Grade 4 |
9.380100E-04 |
| Grade 3-vs-Grade 4 |
4.479700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.22915044598449E-14 |
| Normal-vs-ccB subtype |
2.1094237467878E-15 |
| ccA subtype-vs-ccB subtype |
1.993430E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62725388719309E-12 |
| Normal-vs-N1 |
4.62309999949007E-07 |
| N0-vs-N1 |
2.557400E-01 |
|
|
